Physician profile
Seth Levin
NPI 1992826440
$1,470.60
in general payments reported to CMS, 2019-2025
13 companies · $363 in 2025
The $363 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $67.95 · 2022: $62.09 · 2023: $271 · 2024: $449 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $451.72 | 2019-2025 | |
| Boston Scientific Corporation | $294.49 | 2023-2025 | Exalt Model D, Compliance Endokit, General - Biliary Devices |
| Genzyme Corporation | $255.56 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.00 | 2019 | |
| Aspire Bariatrics, INC. | $78.05 | 2019 | |
| Ambu INC. | $67.95 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.55 | 2019 | |
| Pfizer INC. | $39.92 | 2025 | |
| Qol Medical, LLC | $39.55 | 2025 | Sucraid |
| Phathom Pharmaceuticals, INC. | $38.08 | 2024-2025 | Voquezna |
| Braintree Laboratories, INC. | $26.56 | 2022 | |
| Cook Medical LLC | $17.83 | 2024 | Hemospray |
| Lucid Diagnostics INC. | $14.34 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.